Abbott logo — Life-changing health technologies in the area of diagnostics...

Abbott

Life-changing health technologies in the area of diagnostics, medical devices, nutritionals and branded generic medicines

Founded 1944 United States United States 152808 employees IPO Total: $6.80M Biotechnology, Health Care +4

General Information

Company Name Abbott
Founded Year 1944
Location United States United States
Employees 152808
Industries Biotechnology, Health Care, Manufacturing +3
Funding Stage IPO
Business Model B2C, B2B, D2C
Revenue Model Product Sales, Licensing, Service Fee
Offices as of Aug 2026
Abbott Park, United States

BounceWatch is an independent company data service, not affiliated with Abbott. To contact Abbott, visit abbott.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Abbott compare?

A PDF of Abbott and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Abbott soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

AI Insight

Bounce Watch AI
1 month ago

Abbott is demonstrating robust strategic advancement, marked by the recent U.S. FDA authorization for its Libre Duo 10 Day system and the launch of an innovative infant formula in the U.S. Concurrently, the company is strategically expanding its medical device portfolio with the Amulet™ 360 Left Atrial Appendage Occluder into the European market. These developments highlight Abbott's ongoing commitment to product innovation, regulatory success, and global market expansion across its diverse healthcare segments.

Signal Types
Regulatory Approval Product Launch Market Expansion Partnership Digital Transformation
Strategic Labels
Product Innovation Market Expansion Regulatory Success
Next Move: Commercialization
·
Impact: 8/10
·
Ideal For: Public Market Healthcare Investors

About Abbott

Abbott, founded in 1944, stands as a venerable leader in the global healthcare sector. With a diverse portfolio that spans diagnostics, medical devices, nutritionals, and branded generic medicines, Abbott operates in more than 160 countries, supported by a workforce exceeding 122,000 professionals.

Positioned primarily within the Biotechnology, Health Care, Manufacturing, Medical Devices, Nutrition, and Pharmaceutical industries, the company's core mission encapsulated in their slogan, "Life-changing health technologies in the area of diagnostics, medical devices, nutritionals and branded generic medicines," highlights its commitment to enhancing global health outcomes.

Headquartered in the United States, Abbott raised its last investment of $100.00K through a Post Ipo Debt transaction on 01 March 2011. Although devoid of recent high-profile investments, the company's expansive reach and proven market presence continue to make it a robust entity in the healthcare landscape.

Business keywords: Diagnostics, Nutritionals, Branded Generic Medicines, HIV Treatment, Thyroid Hormone Therapy, Anticonvulsant Drugs, Rheumatoid Arthritis Treatment, Psoriatic Arthritis Treatment, Ankylosing Spondylitis Treatment, Global Healthcare Leader, Life-changing Technologies, Diversity in Workforce, Equal Opportunity Employer

Services & Products

Pharmaceutical Products
Nutritional Products
Medical Devices
Diagnostic Solutions

Target Customers

Urban Populations Rural Communities Healthcare Professionals Infants and Young Children Elderly Population

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt $100.00K -
01 Mar 2011
Post-IPO Debt $6.70M -
01 Mar 2009
IPO Undisclosed -
01 Dec 1980

Abbott Alternatives & Competitors

View All Alternatives
Abbott vs

Pharmaceutical Drugs Manufacturers, Suppliers, Exporters,Dealers in India and worldwide.

14 employees
Health Care, Pharmaceutical
Abbott vs

We’re here to champion long-term health. Get updates on innovation and inspiring stories 💙

IPO
62491 employees
Biotechnology, Pharmaceutical
Abbott vs
Orca Bio
Orca Bio United States

Transforming allogeneic cell therapy for patients with cancer and autoimmune diseases.

Series D
327 employees
Health Care, Pharmaceutical

FAQ About Abbott

Life-changing health technologies in the area of diagnostics, medical devices, nutritionals and branded generic medicines
Abbott was founded in 1944.
Abbott is headquartered in United States. As of Aug 2026, it also has offices in Abbott Park, United States.
Abbott operates in Biotechnology, Health Care, Manufacturing, Medical Devices, Nutrition and Pharmaceutical. Its work centres on Diagnostics, Nutritionals, Branded Generic Medicines and HIV Treatment. Its customers include Urban Populations, Rural Communities and Healthcare Professionals.
Abbott has a B2C, B2B and D2C business model. Its revenue comes from Product Sales, Licensing and Service Fee.
Abbott has approximately 152808 employees.
Abbott has completed 3 funding rounds, raising a total of $6.80M. The latest funding stage is IPO.
Abbott offers: Pharmaceutical Products, Nutritional Products, Medical Devices, Diagnostic Solutions.
Top alternatives and competitors to Abbott include Chawla Medicos, Novo Nordisk, Orca Bio, Zentiva, Primus Remedies Pvt Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Abbott and Chawla Medicos are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Abbott, https://bouncewatch.com/company/abbott-1, updated 15 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes